Table 3 Matrix effect and recovery of decitabine from enzyme digestion matrix (n = 5).

From: Tracking Decitabine Incorporation into Malignant Myeloid Cell DNA in vitro and in vivo by LC-MS/MS with Enzymatic Digestion

[Decitabine] (nM)

[dC] (nM)

[5mdC] (nM)

[dG] (nM)

 

3.00 (LQC)

70.0 (MQC)

1.60 × 103 (HQC)

3.00 (LQC)

70.0 (MQC)

1.60 × 103 (HQC)

3.00 (LQC)

70.0 (MQC)

1.60 × 103 (HQC)

3.00 (LQC)

70.0 (MQC)

1.60 × 103 (HQC)

MFAnaa ± SD

0.959 ± 0.001

0.972 ± 0.001

1.01 ± 0.00

0.964 ± 0.002

0.976 ± 0.002

1.01 ± 0.03

0.933 ± 0.003

0.951 ± 0.006

0.968 ± 0.003

0.943 ± 0.003

0.961 ± 0.007

0.990 ± 0.002

MFISb ± SD

0.977 ± 0.002

0.981 ± 0.001

0.98 ± 0.01

0.977 ± 0.002

0.981 ± 0.001

0.98 ± 0.01

0.977 ± 0.002

0.981 ± 0.001

0.98 ± 0.01

0.977 ± 0.002

0.981 ± 0.001

0.98 ± 0.01

IS Normalized MFc ± SD

0.982 ± 0.002

0.991 ± 0.001

1.03 ± 0.01

0.987 ± 0.003

0.995 ± 0.002

1.03 ± 0.03

0.955 ± 0.004

0.970 ± 0.006

0.988 ± 0.01

0.965 ± 0.004

0.980 ± 0.007

1.01 ± 0.01

RAnad ± SD (%)

91.2 ± 0.2

97 ± 1

100 ± 1

92.6 ± 0.3

98 ± 2

100 ± 2

90.3 ± 0.4

95. ± 3

98 ± 1

90.7 ± 0.5

96 ± 4

99 ± 1

RISe ± SD (%)

91 ± 2

99 ± 3

99 ± 2

91 ± 2

99 ± 3

99 ± 2

91 ± 2

99 ± 3

99 ± 2

91 ± 2

99 ± 3

99 ± 2

IS Normalized Rf ± SD

1.00 ± 0.02

0.98 ± 0.03

1.01 ± 0.02

1.02 ± 0.0

0.99 ± 0.04

1.01 ± 0.03

0.99 ± 0.02

0.96 ± 0.04

0.99 ± 0.02

1.00 ± 0.02

0.97 ± 0.05

1.00 ± 0.02

  1. aMFAna = (mean peak area of analyte in extracted enzyme digestion matrix)/(mean peak area of analyte in the mobile phase).
  2. bMFIS = (mean peak area of IS in extracted enzyme digestion matrix)/(mean peak area of IS in the mobile phase).
  3. cIS Normalized MF = MFAna/MFIS.
  4. dRAna = [(mean peak area of analyte in enzyme digestion matrix)/(mean peak area of analyte in extracted enzyme digestion matrix)] × 100%.
  5. eRIS = [(mean peak area of IS in enzyme digestion matrix)/(mean peak area of IS in extracted enzyme digestion matrix)] × 100%.
  6. fIS Normalized R = (RAna/RIS) × 100%.
  7. Note: IS 2′-Deoxycytidine 15N3 added at a concentration of 200 nM.